Deus Medical NEBIMED 5 – Nebivolol for Cardiovascular Support

Brand: Deus Medical

Substance: Nebivolol

Action of the Drug

NEBIMED 5 is a selective beta-1 blocker with vasodilatory properties that helps regulate blood pressure and improve cardiovascular efficiency, which can be critical during intense training phases.

Use in Sports

While not anabolic, Nebivolol supports athletes by reducing stress on the heart, controlling blood pressure spikes often caused by certain anabolic steroids, and enhancing overall endurance.

Period of Drug Withdrawal

The drug typically clears the system within 1 to 2 days after cessation.

Rate of Suppression of Natural Testosterone Production

NEBIMED 5 does not suppress natural testosterone production, making it safe to use alongside anabolic cycles.

What Should Be Used During and After Use

During use: Monitor blood pressure and consult with healthcare professionals.
After use: No specific post-cycle drugs required for Nebivolol itself, but continue standard PCT if on anabolic steroids.

Combinations with Other Anabolic and Androgenic Drugs

Can be safely stacked with:
- Testosterone esters
- Trenbolone
- Dianabol
- Anavar
- Winstrol
to help manage cardiovascular strain during cycles.

Possible Side Effects and How to Avoid Them

• Fatigue – adjust dosage and ensure adequate rest
• Dizziness – avoid sudden position changes
• Cold extremities – maintain proper circulation with light exercise

Side effects are generally mild and manageable with correct use.

Why We Recommend It

From a trainer's perspective, NEBIMED 5 is a valuable addition to cycles that strain cardiovascular health. It helps maintain stable blood pressure, allowing athletes to train harder and recover better.

Comparison with Other Drugs

Compared to non-selective beta blockers, Nebivolol offers targeted cardiac support with fewer side effects, making it preferable for athletes.

Main Properties

• Drying – Fat Loss: No direct effect.
• Growth of Mass-Strength: Supports performance indirectly by promoting cardiovascular health.